ArticleJournal of surgical oncology2024

Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors.

Michael A Mederos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.